Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Breast mass, COVID-19, Full blood count, Hypertension
Clinical narrative: extremely high blood pressure; Test: PCR, Result: positive; COVID 19; Swollen lymphnodes in left side arm pit; lumps in breasts about 1.5 weeks after booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 17:00 (Lot number: FG3527) at the age of 42 years as dose 3 (booster), single, administered in arm left, administration date 23Mar2021 12:00 (Lot number: El3248) as dose 2, single and administered in arm left, administration date 03Mar2021 12:00 (Lot number: EL3248) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Cephalosporins, reaction(s): "Known allergy: Cephalosporins", notes: Known allergy: Cephalosporins. The following information was reported: VACCINATION FAILURE (medically significant) with onset 22Dec2021, outcome "unknown", described as "Test: PCR, Result: positive"; COVID-19 (medically significant) with onset 22Dec2021, outcome "unknown", described as "COVID 19"; HYPERTENSION (hospitalization) with onset 08Dec2021, outcome "recovered" (2022), described as "extremely high blood pressure"; LYMPHADENOPATHY (non-serious) with onset 23Nov2021, outcome "unknown", described as "Swollen lymphnodes in left side arm pit"; BREAST MASS (non-serious) with onset 23Nov2021, outcome "unknown", described as "lumps in breasts about 1.5 weeks after booster". The patient was hospitalized for hypertension (start date: 08Dec2021). The event "extremely high blood pressure" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (08Dec2021) 200/100, notes: 200/100; full blood count: (03Jan2022) normal, notes: showed 99egfr ( so back to normal); phaeochromocytoma: (22Dec2021) normal, notes: normal; sars-cov-2 test: (22Dec2021) positive, notes: Nasal swab. Therapeutic measures were taken as a result of hypertension. Clinical Course : Swollen lymphnodes in left side arm pit and lumps in breasts about 1.5 weeks after booster , then on 08Dec extremely high blood pressure event above 200/100 and went to ER. All lab tests were normal although note that egfr was 70. Went to GP and got put on HBP meds - losarten with hydrochlorothiozide added on later . Took about 7 days to regulated BP to normal and then followed up with a cardio visit on 03Jan and blood work. Cardio visit ok and however blood work showed 99egfr (so back to normal) was also tested for pheo and it was all normal. There is not clarity on what drove the high blood pressure event from the specialist or GP, except I am back to normal now but on meds for HBP. I wanted to report I case it was booster related. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.